![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
2B-Adrenoceptor
Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas
Increasing the cellular levels of G protein-coupled receptor kinase (GRK) 2 or GRK3 renders the
2B-adrenoceptor (AR) more sensitive to agonist-induced down-regulation (J Pharmacol Exp Ther 312:767773, 2005). However, an absolute requirement of GRK3 and GRK2 for
2B-AR down-regulation is controversial. In this study, using NG108 cells (endogenous
2B-AR), we provide strong evidence for a critical role of both GRK3 and GRK2 in down-regulation of the
2B-AR. Pretreatment of NG108 cells with 20 µM epinephrine (EPI) begins down-regulating the
2B-AR by 2 h. The translocation of GRK3 and GRK2 to the membrane peaks at 30 min, decreasing by 1 h. Although these results may implicate GRK3 and GRK2 in
2B-AR down-regulation, significant receptor down-regulation is not observed until 2 h, after GRK3 and GRK2 translocation has peaked and is declining. To more directly establish a role for GRK3 and GRK2 in
2B-AR down-regulation, NG108 cells were transfected to express GRK3ct, which binds to liberated G
subunits, preventing GRK3 and GRK2 translocation to the membrane. Overexpression of GRK3ct prevented not only the translocation of GRK3 and GRK2 but also the down-regulation of the
2B-AR caused by 24-h pretreatment with 20 µM EPI. Taken together, these data provide direct evidence for a role of GRK3 and GRK2 in the down-regulation of the
2B-AR and contribute significantly to the increasing evidence in the literature for a pivotal role of GRKs in modulating the agonist-induced down-regulation of the
2-AR.
Address correspondence to: Douglas C. Eikenburg, Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204. E-mail: deikenburg{at}uh.edu
This article has been cited by other articles:
![]() |
S. Salim, K. M. Standifer, and D. C. Eikenburg Extracellular Signal-Regulated Kinase 1/2-Mediated Transcriptional Regulation of G-Protein-Coupled Receptor Kinase 3 Expression in Neuronal Cells J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 51 - 59. [Abstract] [Full Text] [PDF] |
||||